Mind-Reading device may give voice to unconscious patients

NCT ID NCT06426602

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Amy Wagner Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a device called mindBEAGLE that reads brain waves to help people with disorders of consciousness answer yes/no questions. Participants wear a cap with sensors, vibrating wristbands, and earphones to learn how to communicate using their thoughts. The goal is to see if this technology can be used daily during inpatient rehabilitation to improve communication and care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mindBEAGLE brain-computer interface device
What this could lead to: If successful, this could provide a way for people with disorders of consciousness to communicate basic yes/no answers, improving their care and quality of life.
What could go wrong: This is an early-stage study with only 40 participants, so results may not apply to everyone. The device may not work for all patients, and training can be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DISORDERS OF CONSCIOUSNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Coma Consciousness Disorders locked-in syndrome Persistent Vegetative State

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DISORDERS OF CONSCIOUSNESS

Contacts and locations

Locations

UPMC Center for Assistive Technology

Pittsburgh, Pennsylvania, 15213, United States
UPMC Rehabilitation Institute

Pittsburgh, Pennsylvania, 15219, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.